A detailed history of Israel Englander (Millennium Management LLC) transactions in Renovo Rx, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 82,353 shares of RNXT stock, worth $102,941. This represents 0.0% of its overall portfolio holdings.

Number of Shares
82,353
Previous 86,316 4.59%
Holding current value
$102,941
Previous $97,000 10.31%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.96 - $1.29 $3,804 - $5,112
-3,963 Reduced 4.59%
82,353 $87,000
Q2 2024

Aug 14, 2024

BUY
$1.02 - $1.46 $88,042 - $126,021
86,316 New
86,316 $97,000

Others Institutions Holding RNXT

About RenovoRx, Inc.


  • Ticker RNXT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,066,860
  • Market Cap $11.3M
  • Description
  • RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...
More about RNXT
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.